201 related articles for article (PubMed ID: 20043149)
1. O-GlcNAc modification of proteins affects volume regulation in Jurkat cells.
Nagy T; Balasa A; Frank D; Rab A; Rideg O; Kotek G; Magyarlaki T; Bogner P; Kovács GL; Miseta A
Eur Biophys J; 2010 Jul; 39(8):1207-17. PubMed ID: 20043149
[TBL] [Abstract][Full Text] [Related]
2. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
Haltiwanger RS; Grove K; Philipsberg GA
J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
Park SY; Ryu J; Lee W
Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
[TBL] [Abstract][Full Text] [Related]
4. Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells.
Matthews JA; Acevedo-Duncan M; Potter RL
Biochim Biophys Acta; 2005 Apr; 1743(3):305-15. PubMed ID: 15843043
[TBL] [Abstract][Full Text] [Related]
5. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
Johnson B; Opimba M; Bernier J
Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
[TBL] [Abstract][Full Text] [Related]
6. Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.
Xing D; Feng W; Nöt LG; Miller AP; Zhang Y; Chen YF; Majid-Hassan E; Chatham JC; Oparil S
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H335-42. PubMed ID: 18469144
[TBL] [Abstract][Full Text] [Related]
7. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
8. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
9. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells.
Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561
[TBL] [Abstract][Full Text] [Related]
10. Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.
Arias EB; Kim J; Cartee GD
Diabetes; 2004 Apr; 53(4):921-30. PubMed ID: 15047606
[TBL] [Abstract][Full Text] [Related]
11. Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils.
Kneass ZT; Marchase RB
J Biol Chem; 2005 Apr; 280(15):14579-85. PubMed ID: 15703172
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome.
Lee JE; Park JH; Moon PG; Baek MC
Proteomics; 2013 Oct; 13(20):2998-3012. PubMed ID: 23946262
[TBL] [Abstract][Full Text] [Related]
13. Relationship between protein O-linked glycosylation and insulin-stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure to O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate.
Arias EB; Cartee GD
Acta Physiol Scand; 2005 Mar; 183(3):281-9. PubMed ID: 15743388
[TBL] [Abstract][Full Text] [Related]
14. Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells.
Matthews JA; Belof JL; Acevedo-Duncan M; Potter RL
Mol Cell Biochem; 2007 Apr; 298(1-2):109-23. PubMed ID: 17136481
[TBL] [Abstract][Full Text] [Related]
15. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
16. PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells.
Mehdy A; Morelle W; Rosnoblet C; Legrand D; Lefebvre T; Duvet S; Foulquier F
J Biochem; 2012 Apr; 151(4):439-46. PubMed ID: 22337894
[TBL] [Abstract][Full Text] [Related]
17. PUGNAc induces protein ubiquitination in C2C12 myotube cells.
Park JH; Lee JE; Moon PG; Baek MC
Cell Biochem Funct; 2015 Dec; 33(8):525-33. PubMed ID: 26531776
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death.
Ngoh GA; Hamid T; Prabhu SD; Jones SP
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1711-9. PubMed ID: 19734355
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAc modification of NFκB p65 inhibits TNF-α-induced inflammatory mediator expression in rat aortic smooth muscle cells.
Xing D; Gong K; Feng W; Nozell SE; Chen YF; Chatham JC; Oparil S
PLoS One; 2011; 6(8):e24021. PubMed ID: 21904602
[TBL] [Abstract][Full Text] [Related]
20. The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels.
Zou L; Yang S; Hu S; Chaudry IH; Marchase RB; Chatham JC
Shock; 2007 Apr; 27(4):402-8. PubMed ID: 17414423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
